Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice - Interim analysis of the non-interventional SCOPE study
Document type:
Meeting Abstract
Author(s):
Bokemeyer, C.; Amram, M. -L.; Stoiber, F.; Gschwend, J. E.